Since 2004, Dr. Seaman’s laboratory has been actively involved in research efforts to study neutralizing antibody responses directed against HIV-1, SHIV, or SIV in the setting of vaccination and/or infection. Dr. Seaman directs the HIV-1 Neutralizing Antibody Core Laboratory that is a component of the Collaboration for AIDS Vaccine Discovery (CAVD) program funded by the Bill and Melinda Gates Foundation. His laboratory uses high-throughput validated assays for measuring neutralizing antibody responses generated by candidate HIV-1 vaccines and broadly neutralizing monoclonal antibodies being developed by collaborators both nationally and internationally.

Honors
1996-1999, NRSA Predoctoral Trainee, NIH #5 T32 CA09082
2000-2002, NRSA Fellow, Postdoctoral Training Program in AIDS Research (Dana-Farber Cancer Institute, NIH #5 T32 AI07386)
2008, Network Citizenship Award, NIH HIV Vaccine Trials Network (HVTN)
2012, Young/Early Career Investigator Award, Collaboration for AIDS Vaccine Development (CAVD)